Guardant Health Quote, Financials, Valuation and Earnings

Guardant Health Price Quote

-0.88 (-3.59%)
(Updated: March 24, 2023 at 12:50 PM ET)

Guardant Health Key Stats

Guardant Health (GH) is a Sell

Day range:
$23.83 - $25.66
52-week range:
$23.83 - $77.72
Dividend yield:
P/E ratio:
P/S ratio:
P/B ratio:

Avg. volume:
1-year change:
Market cap:

How Much Does Guardant Health Make?

Is Guardant Health Growing As A Company?

  • What Is Guardant Health's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.17%
  • What Is Guardant Health's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Guardant Health Stock Price Performance

  • Did Guardant Health Stock Go Up Last Month?
    Guardant Health share price went down by -5.34% last month
  • Did GH's Share Price Rise Over The Last Year?
    GH share price fell by -58.37% over the past 1 year

What Is Guardant Health 52-Week High & Low?

Guardant Health Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Guardant Health?

  • How Much Debt Does Guardant Health Have?
    Total long term debt quarterly is $1.1B
  • How Much Cash Does Guardant Health Have?
    Cash and short term investments quarterly total is $1B
  • What Is Guardant Health’s Book Value Per Share?
    Book value per share is 0.59

Is Guardant Health Cash Flow Positive?

  • What Is GH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$309.5M
  • What Is Guardant Health’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$189.1M
  • What Is Guardant Health’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $149.8M

Guardant Health Return On Invested Capital

  • Is Management Doing A Good Job?
    GH return on invested capital is -44.2%
  • What Is Guardant Health Return On Assets?
    ROA measures how assets are converting to revenues and is -34.45%
  • What Is GH Return On Equity?
    ROE is a measure of profitability and is -189.84%

Guardant Health Earnings Date & Stock Price

Guardant Health Competitors

Guardant Health Dividend Yield

Data Unavailable

Guardant Health Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -1.15%
Revenue: 17.37% 2.44%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 54.25
Upside from Last Price: 121.61%

Major Shareholders

  • How many GH shares are owned by institutional investors?
    168M GH shares are owned by institutional investors
  • How many GH shares are owned by insiders?
    4.1M GH shares are owned by insiders